Monitor for any subsequent Form 4 filings to confirm whether the sale was executed. The endowment's large holding and lack of recent selling suggest this may be a routine portfolio rebalancing rather than a negative signal.
Price Chart
Executive Summary
Lilly Endowment Inc., a major affiliate shareholder of Eli Lilly, filed Form 144 on October 7, 2026, indicating intent to sell 300,000 shares of common stock with an approximate market value of $347 million. While the endowment is not an officer or director, its status as a large, long-term holder makes this a notable signal of potential distribution, though the sale may not be executed.
Key Facts
- Lilly Endowment Inc. filed Form 144 to sell 300,000 shares of Eli Lilly common stock.
- Estimated aggregate market value of the proposed sale is approximately $347,247,000.
- The shares were acquired via a gift from the J.K. Lilly Sr. Trust on February 10, 1948.
- The endowment has not sold any shares in the past three months, per the filing.
- The filing is an advance notice of intent to sell; the actual sale may not occur.
Financial Impact
Proposed sale of 300,000 shares valued at approximately $347 million, representing a small fraction of the endowment's total holdings (38,400,000 shares as of filing date).
Risk Factors
- If the sale is executed, it could create modest short-term selling pressure.
- The filing does not guarantee the sale will occur; the insider may choose not to sell.
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0000316011-26-000031 |
| Document: 0000316011-26-000031-index.html | 0000316011-26-000031 |
| Document: 0000316011-26-000031.txt | 0000316011-26-000031 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 29, 2026 today | 8-K | $1,329.85 | awaiting T+5 | awaiting T+5 | $1,373.29 (+3.27%) |
Oct 26, 2026 3d ago | Press Release | $1,279.14 | awaiting T+5 | awaiting T+5 | $1,373.29 (+7.36%) |
Oct 26, 2026 3d ago | Court Ruling | $1,281.91 | awaiting T+5 | awaiting T+5 | $1,373.29 (+7.13%) |
Oct 19, 2026 9d ago | SC 13G/A | $1,240.34 $1,279.14 | ▲ +3.13% | ▲ +3.27% | $1,373.29 (+10.72%) |
Oct 16, 2026 12d ago | Institutional Cluster | $1,240.34 $1,279.14 | ▲ +3.13% | ▲ +3.27% | $1,373.29 (+10.72%) |
Oct 15, 2026 14d ago | Press Release | $1,251.61 $1,306.69 | ▲ +4.40% | ▲ +5.42% | $1,373.29 (+9.72%) |
Oct 7, 2026 21d ago | 144 | $1,188.72 $1,208.74 | ▲ +1.68% | ▲ +2.66% | $1,373.29 (+15.53%) |
Sep 11, 2026 6w ago | Press Release | $1,115.70 $1,152.93 | ▲ +3.34% | ▲ +3.56% | $1,373.29 (+23.09%) |
Sep 8, 2026 7w ago | Court Ruling | $1,124.21 $1,137.82 | ▲ +1.21% | ▲ +2.31% | $1,373.29 (+22.16%) |
Aug 18, 2026 10w ago | Insider Cluster | $1,280.34 $1,189.41 | ▼ −7.10% | ▼ −6.71% | $1,373.29 (+7.26%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers